Phase 1b Safety and Tolerability of Intradermal BOTOX® (OnabotulinumtoxinA) Purified Neurotoxin Complex in Participants With Facial Fine Lines
Latest Information Update: 23 Nov 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Adverse reactions
- Sponsors Allergan
- 15 Nov 2021 Status changed from active, no longer recruiting to completed.
- 07 Sep 2021 Planned End Date changed from 22 Jun 2022 to 8 Nov 2021.
- 07 Sep 2021 Planned primary completion date changed from 22 Jun 2022 to 8 Nov 2021.